Home LiteratureArticle Details
PMID: 17562817 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation.

The Journal of experimental medicine ·Vol. 204 ·No. 7 ·2007-07-09 ·Pages 1519-24

Ehirchiou D, Xiong Y, Xu G, Chen W, Shi Y, Zhang L

Abstract

Antigen-induced immune suppression, like T cell activation, requires antigen-presenting cells (APCs); however, the role of APCs in mediating these opposing effects is not well understood, especially in vivo. We report that genetic inactivation of CD11b, which is a CD18 subfamily of integrin receptors that is highly expressed on APCs, abolishes orally induced peripheral immune tolerance (oral tolerance) without compromising APC maturation or antigen-specific immune activation. The defective oral tolerance in CD11b(-/-) mice can be restored by adoptive transfer of wild-type APCs. CD11b deficiency leads to enhanced interleukin (IL) 6 production by APCs, which subsequently promotes preferential differentiation of naive T cells to T helper 17 (Th17) cells, which are a T cell lineage characterized by their production of IL-17. Consequently, antigen feeding and immunization of CD11b(-/-) mice results in significant production of IL-17 within the draining lymph nodes that interferes with the establishment of oral tolerance. Together, we conclude that CD11b facilitates oral tolerance by suppressing Th17 immune differentiation.

MeSH Terms
Animals Antigen-Presenting Cells/immunology Antigens/immunology CD11b Antigen/genetics,immunology Cell Differentiation/immunology Cell Division Cytokines/metabolism Hypersensitivity, Delayed Immune Tolerance Interleukin-17/immunology Mice Mice, Knockout T-Lymphocytes/immunology
Chemicals
Antigens CD11b Antigen Cytokines Interleukin-17
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ehirchiou Driss
Center for Vascular and Inflammatory Diseases, Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Xiong Ying
Xu Guangwu
Chen Wanjun
Shi Yufang
Zhang Li
References (27)
27 references, click to expand
  1. The role of Mac-1 (CD11b/CD18) in antigen-induced airway eosinophilia in mice.
    Am J Respir Cell Mol Biol. 2001 Aug;25(2):170-7 PMID: 11509326
  2. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.
    Nat Immunol. 2001 Aug;2(8):725-31 PMID: 11477409
  3. Increased expression of interleukin 17 in inflammatory bowel disease.
    Gut. 2003 Jan;52(1):65-70 PMID: 12477762
  4. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells.
    Nat Med. 2003 Feb;9(2):206-12 PMID: 12514742
  5. Tolerogenic dendritic cells.
    Annu Rev Immunol. 2003;21:685-711 PMID: 12615891
  6. Natural versus adaptive regulatory T cells.
    Nat Rev Immunol. 2003 Mar;3(3):253-7 PMID: 12658273
  7. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.
    J Exp Med. 2003 Dec 15;198(12):1951-7 PMID: 14662908
  8. Antigen-induced regulatory T cells.
    Blood. 2004 Jul 1;104(1):26-33 PMID: 15026316
  9. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease.
    Am J Pathol. 2004 Aug;165(2):609-16 PMID: 15277234
  10. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells.
    Nat Immunol. 2004 Nov;5(11):1124-33 PMID: 15475957
  11. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    J Exp Med. 1982 Jan 1;155(1):96-110 PMID: 6915077
  12. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421-5 PMID: 1370356
  13. Peripheral deletion of antigen-reactive T cells in oral tolerance.
    Nature. 1995 Jul 13;376(6536):177-80 PMID: 7603570
  14. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor.
    J Exp Med. 1996 Apr 1;183(4):1415-26 PMID: 8666900
  15. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice.
    J Clin Invest. 1997 Mar 15;99(6):1340-50 PMID: 9077544
  16. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance.
    J Exp Med. 1998 Apr 6;187(7):1133-8 PMID: 9529329
  17. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.
    J Exp Med. 2005 Jan 17;201(2):233-40 PMID: 15657292
  18. Manifestations of inflammatory arthritis are critically dependent on LFA-1.
    J Immunol. 2005 Mar 15;174(6):3668-75 PMID: 15749905
  19. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
    Nat Immunol. 2005 Nov;6(11):1123-32 PMID: 16200070
  20. Understanding the IL-23-IL-17 immune pathway.
    Trends Immunol. 2006 Jan;27(1):17-23 PMID: 16290228
  21. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.
    Immunity. 2006 Feb;24(2):179-89 PMID: 16473830
  22. Transforming growth factor-beta induces development of the T(H)17 lineage.
    Nature. 2006 May 11;441(7090):231-4 PMID: 16648837
  23. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
    Nature. 2006 May 11;441(7090):235-8 PMID: 16648838
  24. Th17: an effector CD4 T cell lineage with regulatory T cell ties.
    Immunity. 2006 Jun;24(6):677-88 PMID: 16782025
  25. Oral tolerance, an active immunologic process mediated by multiple mechanisms.
    J Clin Invest. 2000 Oct;106(8):935-7 PMID: 11032852
  26. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu.
    Immunity. 2001 Jun;14(6):715-25 PMID: 11420042
  27. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.
    Nat Med. 2002 Sep;8(9):1024-32 PMID: 12145647
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2007-07-09
Epub
2007-00-11
Pages
1519-24
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118631
Subset
IM
Grants
NIAID NIH HHS · R01 AI043384 · United States
NIAID NIH HHS · AI 50222 · United States
NHLBI NIH HHS · 2P01 HL 54710 · United States
NHLBI NIH HHS · R01 HL061589 · United States
NHLBI NIH HHS · P01 HL054710 · United States
NIAID NIH HHS · R01 AI050222 · United States
Intramural NIH HHS · United States
NIAID NIH HHS · AI 43384 · United States
NIAID NIH HHS · R21 AI043384 · United States
NHLBI NIH HHS · R01 HL 61589 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com